Literature DB >> 12550064

Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat.

Isabelle Demonty1, Benoi;t Lamarche, Yves Deshaies, Hélène Jacques.   

Abstract

The present study was undertaken to determine whether isoflavones present in soy protein isolate contribute to the triglyceride-lowering effect of the protein relative to casein. Plasma triglyceride concentrations, their secretion rate into blood circulation, and post-heparin plasma lipoprotein lipase activity (a major determinant of intravascular catabolism of triglycerides) were measured in the fasted state in male Sprague-Dawley rats fed for 21 days one of three experimental diets varying in protein source (20% weight/weight): soy protein isolate, casein or casein to which 1.82 mg/g isoflavones (genistein and daidzein) were added to match the isoflavone content of soy protein isolate. Body weight gain was slightly lower in soy protein fed rats than in casein fed rats, but this effect was not statistically significant (P = 0.22). Casein plus isoflavones diet induced intermediary weight gain. A decrease in plasma total triglycerides was observed in rats fed soy protein and casein plus isoflavones compared with casein (P < 0.05), and there was a tendency to a positive correlation between weight gain and plasma triglyceride concentrations (r = 0.35, P = 0.06). However, no significant effect was observed on hepatic triglyceride concentrations, triglyceride secretion rate by the liver and post-heparin plasma lipoprotein lipase activity. These results show that soy protein isolate, in comparison with casein, has a hypotriglyceridemic effect in the rat and suggest that isoflavones may be responsible, at least in part, for this effect. The lowering effect of soy protein isolate and isoflavones on plasma triglyceride concentrations may be mediated by an alteration in energy balance, and possibly by the hepatic production of lipoproteins more susceptible to intravascular hydrolysis. Subtle but sustained changes in triglyceride secretion and post-heparin plasma lipoprotein lipase activity may also be implicated.

Entities:  

Year:  2002        PMID: 12550064     DOI: 10.1016/s0955-2863(02)00214-0

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  13 in total

Review 1.  Flavonoids and age-related disease: risk, benefits and critical windows.

Authors:  J K Prasain; S H Carlson; J M Wyss
Journal:  Maturitas       Date:  2010-02-23       Impact factor: 4.342

2.  Specific oligopeptides in fermented soybean extract inhibit NF-κB-dependent iNOS and cytokine induction by toll-like receptor ligands.

Authors:  Woo Hyung Lee; Hong Min Wu; Chan Gyu Lee; Dae Il Sung; Hye Jung Song; Toshiro Matsui; Han Bok Kim; Sang Geon Kim
Journal:  J Med Food       Date:  2014-09-03       Impact factor: 2.786

3.  Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in Postmenopausal Women: A Systematic Review and Meta-Analysis.

Authors:  Agata Błaszczuk; Agnieszka Barańska; Wiesław Kanadys; Maria Malm; Monika Elżbieta Jach; Urszula Religioni; Rafał Wróbel; Jolanta Herda; Małgorzata Polz-Dacewicz
Journal:  Nutrients       Date:  2022-06-14       Impact factor: 6.706

Review 4.  Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.

Authors:  Scott Carlson; Ning Peng; Jeevan K Prasain; J Michael Wyss
Journal:  Gend Med       Date:  2008

5.  Interaction between dietary protein and fat in triglyceride metabolism in the rat: effects of soy protein and menhaden oil.

Authors:  Isabelle Demonty; Yves Deshaies; Benoît Lamarche; Hélène Jacques
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

6.  Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus.

Authors:  Patricia Rivera; Margarita Pérez-Martín; Francisco J Pavón; Antonia Serrano; Ana Crespillo; Manuel Cifuentes; María-Dolores López-Ávalos; Jesús M Grondona; Margarita Vida; Pedro Fernández-Llebrez; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats.

Authors:  Tu-Fa Lien; Yu-Lin Hsu; Dan-Yuan Lo; Robin Yy Chiou
Journal:  Nutr Metab (Lond)       Date:  2009-04-09       Impact factor: 4.169

Review 8.  Effects of Soy Isoflavones on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Agnieszka Barańska; Agata Błaszczuk; Małgorzata Polz-Dacewicz; Wiesław Kanadys; Maria Malm; Mariola Janiszewska; Marian Jędrych
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

9.  Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model.

Authors:  Bilal Ustundag; Ibrahim Halil Bahcecioglu; Kazim Sahin; Sevda Duzgun; Suleyman Koca; Funda Gulcu; Ibrahim Hanifi Ozercan
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.487

10.  Antioxidant action of soy isoflavones on oxidative stress and antioxidant enzyme activities in exercised rats.

Authors:  Gun-Ae Yoon; Sunmin Park
Journal:  Nutr Res Pract       Date:  2014-08-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.